Associate Director
Sangamo Therapeutics
Savita Nair is an Associate Director at Sangamo Therapeutics, where she leads the Bio-Assay Development group within the Analytical Development department of Technical Operations at Brisbane, California. She leads a team of scientists and associates to develop, qualify, and implement cell-based analytical assays to support process development and QC release for all drug modalities including genome editing, gene regulation, gene therapy and cell therapy. Prior to Sangamo, Savita worked at Merck, Atrin Pharmaceuticals and Fox Chase Cancer Center in Philadelphia. She has a PhD in Immunology from the University of Duisburg-Essen in Germany.
Savita is also a passionate advocate of Diversity, Equity, Inclusion, Belonging and women empowerment initiatives in the business of healthcare. Sangamo Therapeutics recently recognized her impact as a leader by nominating her for 2023 HBA Rising Star award, an honor bestowed by Healthcare for Businesswomen’s Association, a global nonprofit organization.
Disclosure information not submitted.
Wednesday, April 26, 2023
9:30 AM – 11:00 AM ET
Wednesday, April 26, 2023
2:45 PM – 3:00 PM ET